Relapsed or Refractory Multiple Myeloma

• Research Site — West Hollywood, California, United States
• Research Site — Tampa, Florida, United States
• Research Site — Atlanta, Georgia, United States
• Research Site — Chicago, Illinois, United States

• Robert A Moss Oncology — Fountain Valley, California, United States
• Rocky Mountain Cancer Centers Denver Midtown — Denver, Colorado, United States
• Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut — Plainville, Connecticut, United States
• Baptist MD Anderson Cancer Center — Jacksonville, Florida, United States

• Birmingham Heartlands Hospital — Birmingham, United Kingdom
• Royal Bournemouth Hospital — Bournemouth, United Kingdom
• Leicester Royal Infirmary — Leicester, United Kingdom
• Royal Liverpool University Hospital — Liverpool, United Kingdom

• Universitätsklinikum Köln, Klinik I Innere Medizin — Cologne, Germany
• Mediz. Klinik und Poliklinik 1, Universitätsklinikum Dresden — Dresden, Germany
• Universitätsklinikum Frankfurt, Medizinische Klinik II — Frankfurt am Main, Germany
• University Hospital Heidelberg, Med. Klinik V — Heidelberg, Germany

• Hunan Cancer Hospital — Changsha, Hunan, China

• Mayo Clinic Florida — Jacksonville, Florida, United States
• Mayo Clinic Minnesota — Rochester, Minnesota, United States
• Icahn School of Medicine — New York, United States
• University of Pennsylvania, Abramson Cancer Center — Philadelphia, Pennsylvania, United States

Not specified

• University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. — Mobile, Alabama, United States
• Central Hematology Oncology Medical Group — Alhambra, California, United States
• Central Coast Medical Oncology Corporation — Santa Maria, California, United States
• St. Jude Heritage Medical Group Virginia Crosson Cancer Center — Yorba Linda, California, United States

• Mayo Clinic - Arizona Cancer Clinical Research Unit — Scottsdale, Arizona, United States
• Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) — San Antonio, Texas, United States
• Novartis Investigative Site — Melbourne, Australia
• Novartis Investigative Site — Frankfurt, Germany

Not specified